Zydus Wellness
- Market cap
- ₹ 14,935 Cr.
- P/E
- 66.2x
- P/B
- 2.6x
- 52-week range
- 367.55 – 611.85
- ROE
- 4%
- ROCE
- 5%
- Dividend yield
- 0.3%
- Debt / equity
- 0.55
- Sector
- Food Products
- Industry
- Packaged Foods
- Listed on
- NSE, BSE
About
Zydus Wellness Limited operates as an integrated consumer company. It is engaged in development, production, marketing and distribution of health and wellness products. Its portfolio spans category- food and nutrition brands: RiteBite Max Protein, Complan, Sugar Free, Sugar Free D’Lite, I’m Lite, Glucon-D and Nutralite; dietary supplement brands, including WeightWorld and MaxMedix; pet care brand Animigo; and skincare brands like Everyuth and Nycil. Glucon-D is a glucose powder brand. Glucon-D is available in regular flavors of Tangy Orange & Nimbu Pani. Complan is a nutritional drink designed for growing school children and contains 34 vital nutrients along with 100% milk protein to support growth. Nycil is a prickly heat and cooling powder brand. It offers skin care products under the brand name of Everyuth Naturals. It has four manufacturing facilities across three locations - Aligarh, Ahmedabad and Sikkim. It has 18 co-manufacturing facilities in India, UAE, and New Zealand.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Packaged Foods: 56 companies →Zydus Wellness against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)66.2 against a typical 42.6: pricier than most peers (1st = cheapest).43rd of 56
- Sales growth+66.9% against a typical +15.3% from a year earlier.6th of 45
- Profit growth−7% against a typical +7.5% from a year earlier.26th of 40
- Share price, 3 months−19.6% against a typical −10.1%.36th of 51
- Size₹ 14,935.4 Cr. market value against a typical ₹ 99 Cr. (1st = largest).3rd of 53
Latest announcements
Exchange filings and their impact on the company.
- Zydus Wellness says FSSAI label-claim notice has no material impact after it replied with scientific backing.
Zydus Wellness confirmed it received an FSSAI notice on September 24, 2026 over alleged misleading product claims and replied on October 4, 2026. The company said its label statements are factual and backed by scientific substantiation and it will continue to cooperate with authorities. It stated there is no material impact on the company from the news article.
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 3 Nov 2026Upcoming | Financial Results | To consider and approve the financial results for the period ended September 30, 2026 |
| 4 Aug 2026 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2026 |
| 18 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 3 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 5 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 30 Jul 2025 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2025 |
| 19 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 440 | 403 | 783 | 841 | 493 | 462 | 913 | 861 | 650 | 965 | 1,485 | 1,437 |
| Expenses | 423 | 390 | 620 | 686 | 473 | 447 | 723 | 705 | 628 | 904 | 1,215 | 1,195 |
| Operating Profit | 17 | 13 | 162 | 155 | 20 | 15 | 190 | 156 | 23 | 61 | 270 | 242 |
| OPM % | 3.8% | 3.1% | 21% | 18% | 4% | 3.2% | 21% | 18% | 3.5% | 6% | 18% | 17% |
| Other Income | 4 | 3 | 4 | 5 | 10 | 4 | 1 | 3 | −33 | −6 | 1 | 4 |
| Interest | 6 | 6 | 6 | 4 | 1 | 3 | 4 | 2 | 16 | 41 | 39 | 26 |
| Depreciation | 6 | 6 | 6 | 5 | 5 | 5 | 13 | 11 | 25 | 56 | 55 | 57 |
| Profit before tax | 9 | 4 | 154 | 152 | 24 | 10 | 173 | 145 | −51 | −42 | 177 | 162 |
| Tax % | 31% | 92% | 3% | 3% | 12% | 37% | 1% | 12% | 4% | −4% | 9% | 27% |
| Net Profit | 6 | 0 | 150 | 148 | 21 | 6 | 172 | 128 | −53 | −40 | 162 | 119 |
| EPS in Rs | 0.19 | 0.01 | 4.72 | 4.64 | 0.66 | 0.2 | 5.4 | 4.02 | −1.66 | −1.25 | 5.09 | 3.74 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 26%
- 5 Years
- 16%
- 3 Years
- 21%
- TTM
- 66%
- 10 Years
- 8%
- 5 Years
- −2%
- 3 Years
- −10%
- TTM
- −31%
- 10 Years
- 11%
- 5 Years
- 2%
- 3 Years
- 17%
- TTM
- —
- 10 Years
- 6%
- 5 Years
- 6%
- 3 Years
- 5%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Zydus Wellness | ₹ 466.00 | ₹ 14,935 Cr. | 66.2x | 2.6x | 4% | — |
| Nestle India | ₹ 1,173.45 | ₹ 2,26,278 Cr. | 80.4x | 53.4x | 76.3% | 15.1% |
| Britannia Industries | ₹ 4,547.80 | ₹ 1,09,542 Cr. | 51.5x | 25.5x | 53.6% | 13.3% |
| Godrej Industries | ₹ 918.00 | ₹ 30,884 Cr. | 34.9x | 4x | 11.6% | 10.9% |
| Tata Consumer Products | ₹ 960.00 | ₹ 95,010 Cr. | 67.4x | 4.9x | 7.4% | 8.1% |
| Patanjali Foods | ₹ 351.00 | ₹ 38,193 Cr. | 18.9x | 2.8x | 14.8% | 4.5% |
Management
- Tarun Arora
- Chief Executive Officer, Whole Time Director
- Umesh Vinodray Parikh
- Chief Financial Officer
- Nandish Pradip Joshi
- Company Secretary, Compliance Officer
Prices are delayed and for information only. Nothing on this page is investment advice.